Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study.

Tomoki ItoDavid SanfordCiprian Ionuț TomuleasaHui-Hua HsiaoLeonardo José Enciso OliveraAnoop Kumar EnjetiAlberto Gimenez ConcaTeresa Bernal Del CastilloLarisa GirshovaMaria Paola MartelliBirol GuvencCat N BuiAlex DelgadoYinghui DuanBelen Garbayo GuijarroCynthia LlamasJe-Hwan Lee

Published in: European journal of haematology (2022)

Patients with AML ineligible for intensive therapy have high HRU; novel therapies are needed to alleviate this burden.

Keyphrases

acute myeloid leukemia
healthcare
allogeneic hematopoietic stem cell transplantation
palliative care
locally advanced
stem cells
pain management
risk factors
squamous cell carcinoma
affordable care act
chronic pain
mesenchymal stem cells
health insurance
smoking cessation